Philips appoints chief innovation and strategy officer

Royal Philips (NYSE:PHG) today said it has appointed Shez Partovi as chief innovation and strategy officer, effective July 1.

Partovi replaces Jeroen Tas and will report directly to CEO Frans van Houten. He will also join Philips’s executive committee on March 22 to ensure a seamless transition.

Tas will take on a part-time role at the company to focus on continuing the company’s strategic business development until the end of 2022.

Prior to joining the company, Partovi served as worldwide head of business development for healthcare, life sciences and medical devices and Amazon Web Services. He has also held numerous leadership roles at Dignity Health.

Philips also announced that strategic business development lead Rob Cascella will step down from the executive committee on April 1 to retire. He will remain as a special advisor on a part-time basis until the end of 2021.

“On behalf of Philips’ executive committee, I am ver…

Read more
  • 0

These 5 medtech companies made it into the top 200 of Forbes’ best places to work list

Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees.

Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer to friends and family and to nominate a business that wasn’t their own.

Johnson & Johnson (NYSE:JNJ) ranked 84 out of the full list of 500. The New Brunswick, N.J.-based company has a 4.2 out of 5-star rating on the job board website Glassdoor. Johnson & Johnson, founded in 1886, employs over 132,000 people. Its medical device segment generated $25.96 billion in revenue in 2019.

Mentor, Ohio-based Steris (NYSE:STE) ranked 105 on Forbes’s list of the best large employers in America. The company has a 3.6 out of 5-star rating on Glassdoor. …

Read more
  • 0